chartexchange

CGEN
Compugen Ltd
stockNASDAQ

At CloseNov 13, 2026 3:59:56 PM EST
2.10USD-0.943%(-0.02)209,644
After-hoursNov 13, 2026 4:00:30 PM EST
2.10USD0.000%(0.00)
Loading…
Loading…
198.93M
Healthcare
Biotechnology
HQ
Holon, Israel
Previous Close
$2.12
Beta
1.55
52-Week High
$3.24 2026-04-24
52-Week Low
$1.43 2025-12-30
SMA 50
$2.21
SMA 200
$2.29
Avg. Vol 10D
221,323
Avg. Vol 30D
229,425
Avg. Vol 90D
243,501
Relative Vol
0.91
94.37M
0.6300%
12,221
Mar 1, 2027 (106d)
CGEN Profile

compugen is a leading drug discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology and oncology. the company utilizes a broad and continuously growing integrated infrastructure of proprietary scientific understandings and predictive platforms, algorithms, machine learning systems and other computational biology capabilities for the in silico (by computer) prediction and selection of product candidates, which are then advanced in its pipeline program. the company's business model includes collaborations covering the further development and commercialization of product candidates at various stages from its pipeline program and various forms of research and discovery agreements, in both cases providing compugen with potential milestone payments and royalties on product sales or other forms of revenue sharing. compugen's wholly-owned u.s. subsidiary located in south san francisco is developing monoclonal antib

CGEN Performance
PeriodPriceDateChangeBeta
1W1.962026-11-06+7.14%2.951
1M1.982026-10-13+6.06%1.906
3M2.412026-08-13-12.86%1.379
6M2.852026-05-13-26.32%1.448
1Y1.652025-11-13+27.27%1.551
2Y1.592024-11-13+32.08%—
5Y5.872021-11-12-64.22%1.633
CGEN Stock Summary

Compugen Ltd (NASDAQ:CGEN) stock price today is $2.10, and today's volume is 209,644. CGEN is down 0.943% today. The 30 day average volume is 229,425. CGEN market cap is $198.93M with 94.73M shares outstanding.